3 Biotech Stocks That Sank in 2021 but Could Soar in 2022

3 Biotech Stocks That Sank in 2021 but Could Soar in 2022

There's no denying that 2021 has been a rough year for many biotech stocks. The shares of quite a few big and small biotech companies alike are set to finish the year in negative territory. Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Novartis (NYSE: NVS), and Vertex Pharmaceuticals (NASDAQ: VRTX).